Literature DB >> 12322978

Receptor-independent augmentation of adenovirus-mediated gene transfer with chitosan in vitro.

Yosei Kawamata1, Yuji Nagayama, Kazuhiko Nakao, Hiroyuki Mizuguchi, Takao Hayakawa, Toshinori Sato, Nobuko Ishii.   

Abstract

Recombinant adenovirus is one of the most widely used viral vectors for gene delivery. This study was designed to evaluate the ability of chitosan, a cationic, linear polysaccharide composed of beta(1,4) linked glucosamine partly containing N-acetyl-glucosamine, to enhance the in vitro infectivity of adenovirus to mammalian cells. Wild type and a fiber-mutant replication-defective recombinant adenoviruses expressing beta-galactosidase were used. In the latter, an RGD peptide, the binding site for alpha(v)beta3 and alpha(v)beta5 integrin, was introduced in the fiber knob enabling adenovirus receptor-independent viral infection. Enhanced effect of chitosan on the infectivity of both adenoviruses was observed in Chinese hamster ovary cells that do not express the receptor for adenovirus with beta-galactosidase activity assay and x-gal staining. These data indicate the receptor-independent mechanism(s) for this enhancement effect. In addition, we found that pH of the culture medium, and molecular mass and concentration of chitosan are also critical factors. Thus, the highest effect was obtained with 0.1-1 microg/ml of chitosan with molecular mass of 19K and 40K in the culture medium of pH 6.4; on the other hand, the effect was negligible with the higher chitosan concentrations (10 microg/ml or more), lower or higher molecular mass (11K and 110K) of chitosan, or at pH of 7.4. Studies using several cell lines with variable levels of adenoviral infectivity revealed that this enhanced effect is evident in the cells with poor infectivity to adenovirus. Since chitosan is biocompatible and inexpensive, these data indicate that chitosan may be a potential candidate for a non-viral vector to safely increase adenoviral infectivity to mammalian cells, particularly those with poor susceptibility to adenoviral infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12322978     DOI: 10.1016/s0142-9612(02)00203-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

Review 2.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

Review 3.  At the edge of translation - materials to program cells for directed differentiation.

Authors:  P R Arany; D J Mooney
Journal:  Oral Dis       Date:  2010-09-23       Impact factor: 3.511

4.  Chitosan is a surprising negative modulator of cytotoxic CD8+ T cell responses elicited by adenovirus cancer vaccines.

Authors:  Caitlin D Lemke; Jessica B Graham; Sean M Geary; Gideon Zamba; David M Lubaroff; Aliasger K Salem
Journal:  Mol Pharm       Date:  2011-08-09       Impact factor: 4.939

5.  pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.

Authors:  Joung-Woo Choi; Soo-Jung Jung; Dayananda Kasala; June Kyu Hwang; Jun Hu; You Han Bae; Chae-Ok Yun
Journal:  J Control Release       Date:  2015-01-07       Impact factor: 9.776

6.  Chitosan modification of adenovirus to modify transfection efficiency in bovine corneal epithelial cells.

Authors:  I-Jong Wang; Min-Chao Jhuang; Yu-Hsin Chen; Lung-Kun Yeh; Chia-Yang Liu; Tai-Horng Young
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

Review 7.  Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.

Authors:  Raquel Yokoda; Bolni M Nagalo; Brent Vernon; Rahmi Oklu; Hassan Albadawi; Thomas T DeLeon; Yumei Zhou; Jan B Egan; Dan G Duda; Mitesh J Borad
Journal:  Oncolytic Virother       Date:  2017-11-08

8.  Surfce Functionalized via AdLAMA3 Multilayer Coating for Re-epithelization Around Titanium Implants.

Authors:  Jing Zhang; Yongzheng Li; Jialu Li; Yuan Shi; Jinxing Hu; Guoli Yang
Journal:  Front Bioeng Biotechnol       Date:  2020-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.